Brookside Capital Management Llc - Net Worth and Insider Trading
Brookside Capital Management Llc Net Worth
The estimated net worth of Brookside Capital Management Llc is at least $96 Million dollars as of 2024-11-06. Brookside Capital Management Llc is the 10% Owner of Dicerna Pharmaceuticals Inc and owns about 2,337,000 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $89 Million. Brookside Capital Management Llc is the 10% Owner of Nanosphere Inc and owns about 3,580,180 shares of Nanosphere Inc (NSPH) stock worth over $6 Million. Brookside Capital Management Llc is also the 10% Owner of Concert Pharmaceuticals Inc and owns about 32,789 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $274,444. Details can be seen in Brookside Capital Management Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brookside Capital Management Llc has not made any transactions after 2014-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brookside Capital Management Llc
Brookside Capital Management Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brookside Capital Management Llc owns 8 companies in total, including MuleSoft Inc (MULE) , Radius Health Inc (RDUS) , and Dicerna Pharmaceuticals Inc (DRNA) among others .
Insider Ownership Summary of Brookside Capital Management Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MULE | MuleSoft Inc | 2017-04-04 | 10 percent owner |
| RDUS | Radius Health Inc | 2011-12-31 | 10 percent owner |
| DRNA | Dicerna Pharmaceuticals Inc | 2014-03-11 | 10 percent owner |
 | | 2014-02-12 | 10 percent owner |
| | 2011-07-29 | 10 percent owner |
| | 2004-07-13 | 10 percent owner |
| | 2006-05-23 | 10 percent owner |
| | 2003-12-27 | 10 percent owner |
Brookside Capital Management Llc Latest Holdings Summary
Brookside Capital Management Llc currently owns a total of 3 stocks. Among these stocks, Brookside Capital Management Llc owns 2,337,000 shares of Dicerna Pharmaceuticals Inc (DRNA) as of February 4, 2014, with a value of $89 Million and a weighting of 93.39%. Brookside Capital Management Llc owns 3,580,180 shares of Nanosphere Inc (NSPH) as of July 29, 2011, with a value of $6 Million and a weighting of 6.33%. Brookside Capital Management Llc also owns 32,789 shares of Concert Pharmaceuticals Inc (CNCE) as of February 12, 2014, with a value of $274,444 and a weighting of 0.29%.
Latest Holdings of Brookside Capital Management Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2014-02-04 | 2,337,000 | 38.22 | 89,320,140 |
| NSPH | Nanosphere Inc | 2011-07-29 | 3,580,180 | 1.69 | 6,050,504 |
| CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 32,789 | 8.37 | 274,444 |
Holding Weightings of Brookside Capital Management Llc
Brookside Capital Management Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Brookside Capital Management Llc has made a total of 0 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 0 shares on February 4, 2014, which brought Brookside Capital Management Llc around $0.
According to the SEC Form 4 filings, Brookside Capital Management Llc has made a total of 0 transactions in Nanosphere Inc (NSPH) over the past 5 years. The most-recent trade in Nanosphere Inc is the sale of 892,857 shares on July 29, 2011, which brought Brookside Capital Management Llc around $2 Million.
According to the SEC Form 4 filings, Brookside Capital Management Llc has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 0 shares on February 12, 2014, which brought Brookside Capital Management Llc around $0.
Insider Trading History of Brookside Capital Management Llc
- 1
Brookside Capital Management Llc Trading Performance
Brookside Capital Management Llc Ownership Network
Ownership Network List of Brookside Capital Management Llc
Ownership Network Relation of Brookside Capital Management Llc
Brookside Capital Management Llc Owned Company Details
What does MuleSoft Inc do?
Who are the key executives at MuleSoft Inc?
Brookside Capital Management Llc is the 10 percent owner of MuleSoft Inc. Other key executives at MuleSoft Inc include 10 percent owner M James Barrett , 10 percent owner Lightspeed General Partner Vii, L.p. , and 10 percent owner New Enterprise Associates 14, L.p. .
MuleSoft Inc (MULE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MuleSoft Inc (MULE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MuleSoft Inc (MULE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MuleSoft Inc (MULE)'s detailed insider trading history can be found in Insider Trading Tracker table.
MuleSoft Inc Insider Transactions
Brookside Capital Management Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Brookside Capital Management Llc. You might contact Brookside Capital Management Llc via mailing address: C/o Bain Capital Public Equity, Lp, 200 Clarendon Street, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
